Dexcom (DXCM) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Dexcom (DXCM) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.85% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 33.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.13% |
| Mar 31, 2026 | 92.23% |
| Dec 31, 2025 | 77.74% |
| Sep 30, 2025 | 112.52% |
| Jun 30, 2025 | 27.56% |
| Mar 31, 2025 | -28.17% |
| Dec 31, 2024 | -41.95% |
| Sep 30, 2024 | 9.37% |
| Jun 30, 2024 | 19.94% |
| Mar 31, 2024 | 198.53% |
| Dec 31, 2023 | 181.65% |
| Sep 30, 2023 | 20.26% |
| Jun 30, 2023 | 131.12% |
| Mar 31, 2023 | -49.78% |
| Dec 31, 2022 | 1,820.51% |
| Sep 30, 2022 | 15.27% |
| Jun 30, 2022 | -36.02% |
| Mar 31, 2022 | 70.62% |
| Dec 31, 2021 | -101.26% |
| Sep 30, 2021 | 19.54% |